Molecular and clinical aspects of oropharyngeal squamous cell carcinoma associated with human papillomavirus
Open Access
- 8 August 2021
- journal article
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 11 (2), 31-40
- https://doi.org/10.17650/2313-805x-2021-11-2-31-40
Abstract
Currently, the role of human papillomavirus (HPV) in carcinogenesis is well known: more than 90 % of HPV-positive oropharyngeal squamous cell carcinomas are caused by HPV type 16 (HPV-16). HPV E6 and E7 oncoproteins play a significant role in the development of this tumor. The E6- mediated degradation of suppressor protein p53 results in G2/M-phase checkpoint dysregulation and inhibition of apoptosis. HPV oncoprotein E7 binds to pRb, promoting its degradation and the release of E2F transcription factor. Diagnostic assays for HPV detection include immunohistochemical staining for p16, polymerase chain reaction, in situ hybridization, and next-generation sequencing. Immunohistochemical examination (determination of p16 protein expression) is an economical and very specific way to detect a viral infection. Patients with HPV-positive oropharyngeal squamous cell carcinoma demonstrate significantly better response to treatment and overall survival rates than those with HPV-negative oropharyngeal squamous cell carcinoma. Despite the fact that five-year overall survival rate in patients with HPV-positive oropharyngeal squamous cell carcinoma after treatment exceeds 80 %, some patients have poor survival. Unfortunately, currently available methods of risk stratification still do not endure their timely identification. Further research is needed to address these problems.Keywords
This publication has 64 references indexed in Scilit:
- PapillomavirusesEvolution, Medicine, and Public Health, 2015
- Comprehensive genomic characterization of head and neck squamous cell carcinomasNature, 2015
- Effect of the first federally funded US antismoking national media campaignThe Lancet, 2013
- Tumor suppressor p16 INK4A is necessary for survival of cervical carcinoma cell linesProceedings of the National Academy of Sciences of the United States of America, 2013
- Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK populationBMC Cancer, 2013
- Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ HybridizationInfectious Agents and Cancer, 2012
- The molecular biology of head and neck cancerNature Reviews Cancer, 2010
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerThe New England Journal of Medicine, 2010
- Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesisInternational Journal of Oral Surgery, 1983
- A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions.Proceedings of the National Academy of Sciences of the United States of America, 1983